StockData
Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc. (AVIR) stock

AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$3.96−0.16 (-3.88%)

Close on Nov 17, 2026Market cap $317.61MP/E –Yield –

Atea Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Atea Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2021 was 34.5%. For fiscal 2021 it was 34.5%, against -22.5% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2021Dec 31, 202134.5%+57.0
FY2020Dec 31, 2020-22.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2021Dec 31, 202160.9%–
Q3 FY2021Sep 30, 2021-85.9%–
Q2 FY2021Jun 30, 20212.5%–
Q1 FY2021Mar 31, 202146.5%–

More Atea Pharmaceuticals figures

See a number that looks wrong?